It has been proven that, as maternal age advances, the risk of genetic anomalies in the baby also increases.
The following graph shows the estimated risk of Down syndrome according to maternal age.
Clarix is a non-invasive Prenatal Genetic Test, which allows you to analyze the genetic health of your baby(s) and know its gender in early stages of pregnancy, from week 10, whether you have conceived spontaneously or with the help of an Assisted Reproduction Treatment.
At Ingenes we choose to use non-invasive methods, such as Clarix, which pose no risk to either the mother or the future baby(s), from a sample of maternal blood (peripheral blood), which contains free DNA from the fetus. This technique has a 99% certainty in the result.
This test is ideal for:
Patients coming from an Assisted Reproduction treatment who did not undergo a Preimplantation Genetic Test for aneuploidy (PGT-A).
If you have any questions about the Clarix or are considering choosing this test to feel much more confident about your health and your baby's health, schedule an appointment with our Maternal-Fetal specialists who will show you the best way forward.
"My experience with Ingenes was very calming all because of the staff, they were welcoming and made you feel at ease with everything."
Ingenes McAllen, TX.